Gründung: 28.09.2020
Rechtsform: GmbH
Anzahl Mitarbeiter: 9
Sektoren der Gesundheitswirtschaft:
Technologieschwerpunkt / Versorgungssektor: Biotechnologie
Wir sind: Biotechunternehmen
Kernkompetenz des Unternehmens: We are a clinical-stage company specializing in the activation of regulatory T cells and the development of groundbreaking cellular and biologic therapies. Our focus is on addressing T cell-mediated autoimmune and autoinflammatory diseases.
Through our lead cellular product, Actileucel, we aim to revolutionize the treatment landscape by targeting conditions like Graft-versus-Host Disease (GvHD), a severe complication occurring when donor immune cells attack the recipient's tissues after allogeneic stem cell transplant.
Actileucel, designed to prevent and treat GvHD, effectively utilizes the capabilities of activated regulatory T cells from unmatched third-party donors, aimed to provide a safer and more effective therapy compared to conventional treatments such as immunosuppressants.
Our expertise extends beyond therapy development to efficient manufacturing processes, ensuring timely solutions to pressing medical challenges.
Classified as an Advanced Therapy Medicinal Product (ATMP), Actileucel is manufactured in a lean and fast process, allowing a 24h readiness and a highly competitive pricing. Recently, we achieved a significant milestone by treating the first patient with Actileucel, marking a crucial step forward in advancing treatment options.
Wir bieten folgende Kooperationen / Kooperationspartnerschaften:
Research & Development
Wir bieten folgende Kooperationen / Kooperationspartnerschaften:
Co-Development
Prof. Dr. Andrea Tüttenberg,
Kurz-Vita:
ActiTrexx GmbH - c/o University Medical Center Mainz - Johannes Gutenberg-University Mainz
Langenbeckstr. 1
Building 401
55131 Mainz
Telefon: 06131 / 17 29 17
1. Visibility and Exposure: We can showcase our products, therapies, and achievements to a broad audience, enhancing brand awareness. 2. Networking Opportunities: It facilitates connections with other companies, research institutions, and experts, fostering potential partnerships, collaborations, and projects. 3. Knowledge Exchange: We can learn from and share expertise with other members, leading to mutual enrichment and development. 4. Access to Resources: The network may provide access to funding, experts, technical support, and infrastructure, aiding in the advancement of our therapies and scaling our business. 5. Cross-Industry Perspectives: Participation exposes us to diverse perspectives and innovations, sparking new ideas and approaches to our challenges and goals.